Statins use is associated with poorer glycaemic control in a cohort of hypertensive patients with diabetes and without diabetes

BACKGROUND: The US Federal and Drug Administration (FDA) recently revised statin drug labels to include the information that increases in fasting serum glucose and glycated haemoglobin levels have been reported with the use of statins. Yet in a survey, 87% of the doctors stated that they had never o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liew, Su May, Lee, Ping Yein, Hanafi, Nik Sherina, Ng, Chirk Jenn, Wong, Stalia Siew Lee, Chia, Yook Chin, Lai, Pauline Siew Mei, Zaidi, Nur Farhana Mohd, Khoo, Ee Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003286/
https://www.ncbi.nlm.nih.gov/pubmed/24782916
http://dx.doi.org/10.1186/1758-5996-6-53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003286/
https://www.ncbi.nlm.nih.gov/pubmed/24782916
http://dx.doi.org/10.1186/1758-5996-6-53

Ejemplares similares